1. Home
  2. GRFS vs CLF Comparison

GRFS vs CLF Comparison

Compare GRFS & CLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • CLF
  • Stock Information
  • Founded
  • GRFS 1940
  • CLF 1847
  • Country
  • GRFS Spain
  • CLF United States
  • Employees
  • GRFS N/A
  • CLF N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • CLF Metal Mining
  • Sector
  • GRFS Health Care
  • CLF Basic Materials
  • Exchange
  • GRFS Nasdaq
  • CLF Nasdaq
  • Market Cap
  • GRFS 5.5B
  • CLF 4.9B
  • IPO Year
  • GRFS 2006
  • CLF N/A
  • Fundamental
  • Price
  • GRFS $7.27
  • CLF $10.27
  • Analyst Decision
  • GRFS Strong Sell
  • CLF Buy
  • Analyst Count
  • GRFS 1
  • CLF 12
  • Target Price
  • GRFS N/A
  • CLF $16.78
  • AVG Volume (30 Days)
  • GRFS 704.7K
  • CLF 15.7M
  • Earning Date
  • GRFS 01-01-0001
  • CLF 02-24-2025
  • Dividend Yield
  • GRFS N/A
  • CLF N/A
  • EPS Growth
  • GRFS N/A
  • CLF N/A
  • EPS
  • GRFS 0.27
  • CLF N/A
  • Revenue
  • GRFS $7,814,096,584.00
  • CLF $19,972,000,000.00
  • Revenue This Year
  • GRFS $9.31
  • CLF N/A
  • Revenue Next Year
  • GRFS $7.44
  • CLF $4.95
  • P/E Ratio
  • GRFS $31.76
  • CLF N/A
  • Revenue Growth
  • GRFS 7.21
  • CLF N/A
  • 52 Week Low
  • GRFS $5.30
  • CLF $8.99
  • 52 Week High
  • GRFS $9.96
  • CLF $22.97
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 43.85
  • CLF 49.25
  • Support Level
  • GRFS $7.00
  • CLF $9.52
  • Resistance Level
  • GRFS $7.53
  • CLF $10.61
  • Average True Range (ATR)
  • GRFS 0.24
  • CLF 0.45
  • MACD
  • GRFS -0.01
  • CLF 0.18
  • Stochastic Oscillator
  • GRFS 27.00
  • CLF 79.01

About GRFS Grifols S.A.

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

About CLF Cleveland-Cliffs Inc.

Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.

Share on Social Networks: